Purchases and Sales Made in Q1 2024 in Centessa Pharmaceuticals PLC (CNTA)
This table provides information about the institutional ownership of Centessa Pharmaceuticals PLC (CNTA) during Q1 2024. The information is specifically focused on institutions that hold shares of Centessa Pharmaceuticals plc.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 05, 2024
Q1 2024
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-501- 44.85% |
$3.37K - $6.11K
|
616
$9.63K
|
|
|
May 10, 2024
Q1 2024
|
Citigroup Inc
|
SELL
|
- |
-795- 79.58% |
$5.35K - $9.7K
|
204
$3.19K
|
|
|
May 15, 2024
Q1 2024
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-1.29K- 56.14% |
$8.7K - $15.8K
|
1.01K
$15.8K
|
|
|
May 10, 2024
Q1 2024
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
SELL
|
- |
-1.7K- 84.98% |
$11.4K - $20.7K
|
300
$4.69K
|
|
|
May 01, 2024
Q1 2024
|
Compagnie Lombard Odier S Cm A
1204 Geneva, V8 |
SELL
|
- |
-5.82KClosed |
$39.2K - $71K
|
0
$0
|
|
|
May 15, 2024
Q1 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-53.8K- 53.41% |
$362K - $657K
|
47K
$735K
|
|
|
Dec 26, 2024
Q1 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-109K- 79.94% |
$731K - $1.33M
|
27.3K
$426K
|
|
|
May 15, 2024
Q1 2024
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
SELL
|
- |
-646K- 22.31% |
$4.35M - $7.88M
|
2.25M
$35.2M
|